ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,351.15
0.08%
US Tech 100
18,585.20
0.36%
다우존스 지수
38,750.20
-0.13%
Bitcoin
69,843.99
0.27%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. TELA Bio Inc (TELA)

  7. TELA Bio Inc (TELA) 뉴스

TELA

TELA Bio (TELA)

TELA Bio Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:TELA
일자시간출처헤드라인심볼기업
2024/06/1022:00Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TELATELA Bio Inc
2024/06/0706:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TELATELA Bio Inc
2024/06/0705:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TELATELA Bio Inc
2024/06/0705:55Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TELATELA Bio Inc
2024/06/0705:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TELATELA Bio Inc
2024/06/0505:05GlobeNewswire Inc.TELA Bio Appoints Jeffrey Blizard to its Board of DirectorsNASDAQ:TELATELA Bio Inc
2024/05/2105:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TELATELA Bio Inc
2024/05/2105:03GlobeNewswire Inc.TELA Bio Appoints Greg Firestone as Chief Commercial OfficerNASDAQ:TELATELA Bio Inc
2024/05/1105:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TELATELA Bio Inc
2024/05/1105:05GlobeNewswire Inc.TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TELATELA Bio Inc
2024/05/1005:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TELATELA Bio Inc
2024/05/1005:05GlobeNewswire Inc.TELA Bio Reports First Quarter 2024 Financial ResultsNASDAQ:TELATELA Bio Inc
2024/04/2520:00GlobeNewswire Inc.TELA Bio to Announce First Quarter 2024 Financial ResultsNASDAQ:TELATELA Bio Inc
2024/04/1520:00GlobeNewswire Inc.TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia ProceduresNASDAQ:TELATELA Bio Inc
2024/04/0820:00GlobeNewswire Inc.TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon StrategyNASDAQ:TELATELA Bio Inc
2024/03/2205:05GlobeNewswire Inc.TELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial ResultsNASDAQ:TELATELA Bio Inc
2024/03/2120:00GlobeNewswire Inc.TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia SurgeryNASDAQ:TELATELA Bio Inc
2024/03/2020:00GlobeNewswire Inc.MIMEDX Expands Portfolio with Fibrillar Collagen Wound DressingNASDAQ:TELATELA Bio Inc
2024/03/2020:00GlobeNewswire Inc.TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDXNASDAQ:TELATELA Bio Inc
2024/02/2921:00GlobeNewswire Inc.TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:TELATELA Bio Inc
2024/02/2806:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TELATELA Bio Inc
2024/02/2806:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TELATELA Bio Inc
2024/02/2806:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TELATELA Bio Inc
2024/02/2406:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TELATELA Bio Inc
2024/02/2406:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TELATELA Bio Inc
2024/02/2406:05GlobeNewswire Inc.TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:TELATELA Bio Inc
2024/02/1706:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TELATELA Bio Inc
2024/02/1706:05Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:TELATELA Bio Inc
2024/02/1507:23Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:TELATELA Bio Inc
2024/02/1420:35Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:TELATELA Bio Inc
 검색 관련기사 보기:NASDAQ:TELA

최근 히스토리

USOTC
BASFY
BASF (QX)
COIN
ETHUSD
Ethereum
AMEX
XLV
Health Care Select Sector
CCOM
US100
US Tech 100
PM
XAUUSD
Gold vs US Dollar
USOTC
DTEGY
Deutsche Telekom (QX)
FX
USDEUR
US Dollar vs Euro
USOTC
ADDYY
Adidas (QX)
NASDAQ
GOOGL
Alphabet
SPI
SP500
S&P 500
NASDAQ
MSFT
Microsoft
NYSE
JPM
JP Morgan Chase
NYSE
BAC
Bank of America
NYSE
KO
Coca Cola
NYSE
AXP
American Express
NASDAQ
QQQ
Invesco QQQ Trust Series 1
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유